China approves homegrown Covid-19 vaccine for general public use

China approved its first COVID-19 vaccine for general public use on Thursday, a shot developed by state-backed pharmaceutical giant Sinopharm, as it braces for greater transmission risks over the winter. No detailed efficacy data of the vaccine has been publicly released but its developer, Beijing Biological Products Institute, a unit of Sinopharm subsidiary China National […]